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FOREWORD
This volume is a Festschrift presented to John Rodman Paul by his
students and colleagues throughout the world, as an expression of affection
and esteem. It marks his retirement on 30 June 1961, as Professor of
Preventive Medicine at Yale. Happily this retirement does not mean with-
drawal from the scene of action, for on 1 July 1961, he became director
of the World Health Organization Serum Reference Bank, located in the
Department of Epidemiology and Public Health at Yale. His new laboratory
is one of three recently established centers (the other two being in Johan-
nesburg and Prague) for the development of serologic epidemiology on
an international scale. Thus he is continuing a career at Yale which began
some 33 years ago, when he came to New Haven at the invitation of
Dr. Francis G. Blake, then chairman of the Department of Medicine. He
was first appointed assistant and later associate professor of Medicine.
In 1940, the Section of Preventive Medicine was created within the De-
partment of Medicine, with Dr. Paul as professor and chairman.
John Paul's contributions to medicine cover a wide range, represented to
some degree by the titles of the papers in the present volume. Although the
subjects to which he has devoted himself have been diverse, there has been a
unifying theme in his approach to them. This arises from a philosophical
turn of mind which very early caused him to view the problems of
disease in the long perspective. From the beginning of his career he held
the conviction that "clinical medicine means more than the practice
of the technics of diagnosis and therapeutics, for, although it deals primarily
with the care of the sick individual, it is also concerned with the whole
subject of disease in living people".' In 19382 he proposed the term clinical
epidemiology - "for a new science, - concerned with circumstances,
whether they are 'functional' or 'organic', under which human disease is
prone to develop. It is a science concerned with the ecology of human
disease. But it is more than that, for any science worthy to be qualified by
the name Clinical, should involve some attempt at the interpretation of the
circumstances with which it deals. It must face the quetsion 'why', as
well as 'how'."
This approach, as he has so often stressed, is equally applicable to in-
fectious and non-infectious diseases; its usefulness "lies not only in the
discovery of new intrinsic or extrinsic factors, which may be found either
indoors or outdoors, but in the discovery of new concepts. This includes the
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concept of certain new etiologic forces which lie back of those which were
once thought to be basic such as, for instance, the factors which lie back of
the pneumococcus as a cause of pneumonia. Of late years conservative
opinion does not allow anything to be really considered as 'etiology' unless
we can succeed in getting it into a test tube, unless we can precipitate it,
-unless we can crystallize it as it were. This is due, of course, to our
current methodology which has, perhaps, become more of a religion than
most of us realize. I think it may have led to a slightly narrow interpre-
tation of clinical investigation on our part, for clinical investigation certainly
should be given the opportunity to spread itself up into philosophy, if it
will, as well as down into the basic sciences."
In the twenty-three years since these words were written, progress has
been made; with considerable struggle, epidemiology is coming into its
own as a basic and a clinical science, and its potentialities, forseen so clearly
by Dr. Paul, are gradually being realized. During these years, he has been
in the thick of the battle as an investigator and teacher, organizing and
carrying out both frontal and flank attacks on various epidemiological prob-
lems at home and abroad. A year and a half ago, he had occasion to dictate
an informal history of research in the Section of Preventive Medicine, with
some notes on earlier work carried out while he was assistant and associate
professor of Medicine. The transcription of this dictation he has never seen.
Nevertheless, we are taking the liberty of presenting it here, without his
knowledge (and with only minor editing) as a personal record of the
pleasures of scientific exploration and discovery in the mid-20th century
by a physician, a clinical epidemiologist, a naturalist, and a philosopher,-
viz. J.R.P.
DOROTHY M. HORSTMANN
(Guest Editor).
FROM THE NOTEBOOK OF JOHN RODMAN PAUL
"At an earlier date, some four or five months ago, I dictated an outline of
the activities of the Department of Medicine during the 1920's and '30's
with emphasis upon the work of Blake and Trask on scarlet fever, their
recognition of the scarlatinal toxin, and the use of antisera in the therapy
of the disease. This was at a time when scarlet fever was a much more
serious disease than it is at present. The report also emphasized Dr. Blake's
work on pneumococcal pneumonia, his discovery and classification of
pneumococcus variance, and later a great deal of work on the therapy of
pneumonia, both by pneumothorax and later by chemotherapy and anti-
biotics.
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